A MONOCLONAL-ANTIBODY THAT RECOGNIZES SIALYL-LEA OLIGOSACCHARIDE, BUT IS DISTINCT FROM NS-19-9 AS TO EPITOPE RECOGNITION
A MONOCLONAL-ANTIBODY THAT RECOGNIZES SIALYL-LEA OLIGOSACCHARIDE, BUT IS DISTINCT FROM NS-19-9 AS TO EPITOPE RECOGNITION
复制标题
DOI:
10.1093/oxfordjournals.jbchem.a122555
复制
发表时间:
1988-11-01
影响因子:
2.7
通讯作者:
YAMASHINA, I
中科院分区:
文献类型:
--
作者:
KITAGAWA, H;NAKADA, H;YAMASHINA, I
A murine monoclonal antibody, designated as MSW 113, was generated using a human colonic cancer cell line, SW 1116, as the immunogen. MSW 113 was shown to be directed mainly to mucin-type oligosaccharide with sialyl-Lea antigens. The reactivity of MSW 113 to sialyl-Lea was stronger than that of NS 19-9, which is believed to be raised against the same determinant group, MSW 113 binds to sialyl-Lea-ol, LS-tetrasaccharide .alpha., and disialyllacto-N-tetraose with higher affinities, compared to NS 19-9. These two antibodies could clearly be distinguished in that MSW 113 bound to sialic acid but not to fucose, whereas NS 19-9 bound to fucose but not to sialic acid. Thus, MSW 113 is directed more toward sialic acid-containing terminal structures while NS 19-9 is directed toward fucose-containing internal structures. MSW 113 was found to be useful for detecting antigens in the bloodstream of patients, especially those with pancreas cancer. Even NS 19-9 negative patient sera were positive for MSW 113.